Research/art/teacher profile of a person
Name and surname:
doc. RNDr. Vladimíra Ďurmanová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Ďurmanová
I.2 - Name
Vladimíra
I.3 - Degrees
assoc. prof., RNDr., PhD.
I.4 - Year of birth
1974
I.5 - Name of the workplace
Institute of Immunology, Faculty of Medicine, Comenius University in Bratislava
I.6 - Address of the workplace
Odborárske nám. 14, 811 08 Bratislava
I.7 - Position
University Teacher - Associate Professor
I.8 - E-mail address
vladimira.durmanova@fmed.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5446
I.10 - Name of the study field in which a person works at the university
Immunology
I.11 - ORCID iD
0000-0001-7422-0194

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Natural Sciences, Comenius University in Bratislava
II.b - Year
1998
II.c - Study field and programme
study field biology, programme cytology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Institute of Virology, Slovak Academy of Sciences, Bratislava
II.b - Year
2002
II.c - Study field and programme
Virology
II.4 - Associate professor
II.a - Name of the university or institution
University of Veterinary Medicine and Pharmacy in Košice
II.b - Year
2014
II.c - Study field and programme
Immunology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Researcher Institute of Virology, Slovak Academy of Sciences, Bratislava 2002-2008
Teaching assistent Institute of Imunology, Faculty of Medicine, Comenius University in Bratislava 2008-2015
Associate professor Institute of Imunology, Faculty of Medicine, Comenius University in Bratislava 2015 -

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Innovative teaching course "Team-based learning" Faculty of Medicine, Comenius University in Bratislava 2018

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Immunology General Medicine I+II. General Medicine
Immunology Dentistry I+II. Dentistry
Medical Immunology Biomedical Physics I. Physics
New trends in medical microbiology and immunology Medical microbiology and immunology III. General Medicine
PhD thesis I+II, PhD exam, PhD thesis defence Medical microbiology and immunology III. General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Biomedical Physics I. Physics
Medical microbiology and immunology III. General Medicine
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
3
V.4.c - Dissertation (third degree)
1
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
16
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Clinical Immunology General Medicine II. General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
155
VI.1.b - Over the last six years
58
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
52
VI.1.b - Over the last six years
20
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
319
VI.1.b - Over the last six years
172
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
316
VI.1.b - Over the last six years
172
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Fislova T, Gocnik M, Sladkova T, Durmanova V, Rajcani J, Vareckova E, Mucha V, Kostolansky F. Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch Virol. 2009; 154(3): 409-419. (IF 2009 = 1,909, Q4)

2

Sapak M, Chrenova S, Tirpakova J, Zilinska Z, Durmanova V, Shawkatova I, Jakus V, Kuba D, Buc M. Donor non-specific MICA antibodies in renal transplant recipients. Immunobiology. 2014; 219(2): 109-112. (IF 2014=3,044, Q2)

3

Durmanova V, Parnicka Z, Javor J, Minarik G, Vrazda L, Vaseckova B, Gmitterova K, Kralova M, Pecenak J, Filipcik P, Shawkatova I. A novel association of polymorphism in the ITGA4 gene encoding the VLA-4 α4 subunit with increased risk of Alzheimer’s disease. Mediators of Inflammation. 2018; Article ID 7623823:1-8. (IF 2018=3,545, Q2)

4

Durmanova V, Bandzuchova H, Zilinska Z, Tirpakova J, Kuba D, Buc M, Polakova K. Association of HLA-G polymorphisms in the 3‘UTR region and soluble HLA-G with kidney graft outcome. Immunological Investigations. 2019; 48(6): 644-658. (IF 2019 = 2,511, Q3)

5

Durmanova V, Mikolaskova I, Zsemlye E, Ocenasova A, Bandzuchova H, Suchankova M, Kollarik B, Palacka P, Zvarik M, Bucova M, Hunakova L. Association of HLA-G Expression, Its Genetic Variants and Related Neuro-Immunomodulation with Characteristics of Bladder Carcinoma. Cancers. 2024;16(22). (IF 2023 = 4,5, Q1)

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Durmanova V, Bandzuchova H, Zilinska Z, Tirpakova J, Kuba D, Buc M, Polakova K. Association of HLA-G polymorphisms in the 3‘UTR region and soluble HLA-G with kidney graft outcome. Immunological Investigations. 2019; 48(6): 644-658. (IF 2019=2,511, Q3)

2

Bucova M, Kluckova K, Kozak J, Rychly B, Suchankova M, Svajdler M, Matejcik V, Steno J, Zsemlye E, Durmanova V. HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients. Diagnostics. 2022, 12(5): 1099 (IF 2022= 3,6, Q2)

3

Ocenasova A, Shawkatova I, Javor J, Parnicka Z, Minarik G, Kralova M, Kiralyova I, Mikolaskova I, Durmanova V. MMP2 rs243866 and rs2285053 Polymorphisms and Alzheimer's Disease Risk in Slovak Caucasian Population. Life (Basel). 2023, 13(4): 882. (IF 2023= 3,2, Q1)

4

Durmanova V, Tedla M, Rada D, Bandzuchova H, Kuba D, Suchankova M, Ocenasova A, Bucova M. Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients. Diseases. 2024;12(2). (IF 2023 = 2,9, Q2)

5

Durmanova V, Mikolaskova I, Zsemlye E, Ocenasova A, Bandzuchova H, Suchankova M, Kollarik B, Palacka P, Zvarik M, Bucova M, Hunakova L. Association of HLA-G Expression, Its Genetic Variants and Related Neuro-Immunomodulation with Characteristics of Bladder Carcinoma. Cancers. 2024; 16(22). (IF 2023 = 4,5, Q1)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Fislova T, Gocnik M, Sladkova T, Durmanova V, Rajcani J, Vareckova E, Mucha V, Kostolansky F. Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch Virol. 2009; 154(3): 409-419. Cited in: Kenney AD, McMichael TM, Imas A, et al. IFITM3 protects the heart during influenza virus infection. Proc Natl Acad Sci U S A. 2019, 116(37): 18607-18612.

2

Sapak M, Chrenova S, Tirpakova J, Zilinska Z, Durmanova V, Shawkatova I, Jakus V, Kuba D, Buc M. Donor non-specific MICA antibodies in renal transplant recipients. Immunobiology. 2014; 219(2): 109-112. Cited in: Farouk S, Zhang Z, Menon MC. Non-HLA donor-recipient mismatches in kidney transplantation- A stone left unturned. Am J Transplant. 2020, 20(1): 19- 24.

3

Durmanova V, Parnicka Z, Javor J, Minarik G, Vrazda L, Vaseckova B, Gmitterova K, Kralova M, Pecenak J, Filipcik P, Shawkatova I. A novel association of polymorphism in the ITGA4 gene encoding the VLA-4 α4 subunit with increased risk of Alzheimer’s disease. Mediators of Inflammation. 2018; Article ID 7623823:1-8. Cited in: Jaudon, F., Thalhammer, A., Cingolani, L.A. Integrin adhesion in brain assembly: From molecular structure to neuropsychiatric disorders. European Journal of Neuroscience 2021, 53(12): 3831-3850.

4

Durmanova V, Bandzuchova H, Zilinska Z, Tirpakova J, Kuba D, Buc M, Polakova K. Association of HLA-G polymorphisms in the 3‘UTR region and soluble HLA-G with kidney graft outcome. Immunological Investigations. 2019; 48(6): 644-658. Cited in: Walczak M, Lykowska-Szuber L, Plucinska M, Stawczyk-Eder K, Zakerska-Banaszak O, Eder P, Krela-Kazmierczak I, Michalak M, Zywicki M, Karlowski WM,Szalata M, Dobrowolska A, Slomski R, Skrzypczak-Zielinska M. Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients? Front Pharmacol. 2020, 11: 1207.

5

Bucova M, Kluckova K, Kozak J, Rychly B, Suchankova M, Svajdler M, Matejcik V, Steno J, Zsemlye E, Durmanova V. HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients. Diagnostics (Basel). 2022, 12(5): 1099 Cited in: Ji H, Liu Z, Wang F, Sun H, Wang N, Liu Y, Hu S and You C. Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction. Frontiers in Immunology 2022, 13, 941556.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

VEGA 1/0738/20: Biomarkers of neuroinflammation in patients with Alzheimer's disease. Representative of principal investigator.

2

VEGA 1/0426/24: Molecular mechanisms of fibrotic and inflammatory processes of diffuse parenchymal lung diseases - analyzes of defined markers in bronchoalveolar lavages and their significance in clinical practice. Co-worker.

3

APVV-22-0231: Therapeutic potential of a stress-reducing intervention in a complex oncology care. Co-worker.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
German Cancer Research Center Im Neuenheimer Feld 280, 69120 Heidelberg, Germany June 2002 - July 2002 Fellowship stay in the Laboratory of Tumor Virology of Dr. Knopf, fellowship was funded by the organisation BMBF in Bonn (Nr. 00/006).

IX. - Other relevant facts

Date of last update
2025-01-20